EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparison of the excretory capacities of erythropoietin and U-74389G concerning serum creatinine levels

Constantinos Tsompos, Constantinos Panoulis, Konstantinos Toutouzas, Aggeliki Triantafyllou, George Zografos, Apostolos Papalois

Revista Urología Colombiana / Colombian Urology Journal · 2018

DOI: 10.1016/j.uroco.2017.03.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Urología Colombiana / Colombian Urology Journal, 2018. Verfasst von Constantinos Tsompos und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study compared the excretory effects, the erythropoietin (Epo) and antioxidant drug U-74389G exert on serum creatinine levels through kidneys. 2 preliminary studies were used for this purpose including respectively one drug used in a renal ischemia–reperfusion (IR) protocol of an animal model. The preliminary studies are part of the present work. The subjects were pretreated in preliminary studies but the results of the same subjects were simply compared in the current work. Materials and methods The serum creatinine levels were evaluated at the 60th reperfusion min (for groups A, C and E) and at the 120th reperfusion min (for groups B, D and F) after IR in the 60 rats. Groups A and B received no drugs, rats from groups C and D were administered with Epo, whereas rats from groups E and F were administered with U-74389G.

Results

The first preliminary study recommended a non-significant excretory effect of Epo (p-value = 0.4430 > 0.05) than placebo for serum creatinine levels. The second preliminary study proved a very significant excretory effect of U-74389G (p-value = 0.0005 < 0.05) than placebo for serum creatinine levels. These 2 studies were co-evaluated since they came from the same experimental setting. The outcome of the co-evaluation was that U-74389G has at least 5-fold significant excretory action (p-value = 0.0000 < 0.05) than Epo for serum creatinine levels.

Conclusions

The U-74389G presents surprising effective excretory potencies for serum creatinine levels maybe of great importance in hemodialysis patients.

Zitieren

APA

Tsompos, C., Panoulis, C., Toutouzas, K., Triantafyllou, A., Zografos, G., & Papalois, A. (2018). Comparison of the excretory capacities of erythropoietin and U-74389G concerning serum creatinine levels. Revista Urología Colombiana / Colombian Urology Journal. https://doi.org/10.1016/j.uroco.2017.03.006

Vancouver

Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. Comparison of the excretory capacities of erythropoietin and U-74389G concerning serum creatinine levels. Revista Urología Colombiana / Colombian Urology Journal. 2018. doi:10.1016/j.uroco.2017.03.006

BibTeX
@article{Tsompos2018,
  author = {Tsompos, Constantinos and Panoulis, Constantinos and Toutouzas, Konstantinos and Triantafyllou, Aggeliki and Zografos, George and Papalois, Apostolos},
  title = {Comparison of the excretory capacities of erythropoietin and U-74389G concerning serum creatinine levels},
  journal = {Revista Urología Colombiana / Colombian Urology Journal},
  year = {2018},
  doi = {10.1016/j.uroco.2017.03.006}
}
Kostenlos starten →